Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the efficacy and safety of Yiqi Wenyang Sanhan Formula combined with acupoint application in patients with allergic rhinitis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiqi Wenyang Sanhan Formula

Snippet

Sponsor: Beijing Daxing District Hospital of Integrated Chinese and Western Medicine | Conditions: Allergic Rhinitis With Asthma | Phase 1 | Status: NOT_YET_RECRUITING